| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |